71679例患者抗-HCV检测结果分析  

Analysis of Anti-HCV Antibodies in 71 679 patients with Hepatitis C

作　　者：黄素兰[1] 

机构地区：[1]广西钦州市第一人民医院,535000

出　　处：《临床输血与检验》2014年第2期136-139,共4页Journal of Clinical Transfusion and Laboratory Medicine

摘　　要：目的 探讨本地区就诊患者的丙型肝炎感染情况.方法 采用酶联免疫吸附试验（ELISA）对2009～2012年71 679例住院及门诊患者的血液进行丙型肝炎病毒抗体（抗-HCV）检测.结果 就诊患者的抗-HCV阳性率为1.26％;内科的阳性率最高,为1.50％,其次分别为外科1.24％、门诊1.07％、妇科0.84％;男、女阳性率分别为1.39％、1.06％,感染者年龄大多为41～50岁.结论 应加强对公众的丙肝防治健康教育工作,及早控制传染源,切断传播途径,防止丙型肝炎病毒的蔓延和传播.Objective In order to explore the prevalence of hepatitis C in population of Qinzhou city, Guangxi. Methods antibodies against hepatitis C virus（anti-HCV） were detected in 71 679 patients by enzyme-linked immunosor- bent assay （ELISA） in 2009%2012. Results The positive rate of anti-HCV was 1.26%; the highest positive rate was found to be 1.50% in the patients of internal medicine, followed by 1.24 % in surgery, 1.07 % in outpatient service ,and 0. 84% in gynecology. Both males and females had positive rates of 1.39% and 1.06%, respectively. The highest prevalence was found to be in those between the age of 41 and 50. Conclusion Prevention and public health education of hepatitis C need to be strengthened, and the source of infection should be brought under control to terminate the route of transmis- sion.

关 键 词：丙型肝炎病毒抗体 酶联免疫吸附试验 

分 类 号：R512.63[医药卫生—内科学] R446.61[医药卫生—临床医学]